Topical Tranexamic Acid in Total Knee Arthroplasty Patients with Increased Thromboembolic Risk

Journal of Knee Surgery

Volumn 30, Issue 5, 2017, Pages 474-478

  Spanyer, Jonathon ^a   Patel, Jay ^a   Emberton, Eric ^a   Smith, Langan S ^b   Malkani, Arthur L ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b KOH Physicians Group   (United States)

Author keywords

TKA; tranexamic acid; venous thromboembolism risk

Indexed keywords

HEMOGLOBIN; LOW MOLECULAR WEIGHT HEPARIN; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BLOOD TRANSFUSION; COMORBIDITY; CONTROLLED STUDY; DEATH; DEEP VEIN THROMBOSIS; DEMOGRAPHY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART INFARCTION; HEMARTHROSIS; HEMATOMA; HIGH RISK POPULATION; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VEIN; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; RISK FACTOR; TOTAL KNEE ARTHROPLASTY; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; ADVERSE EFFECTS; AGED; BLOOD LOSS, SURGICAL; CHEMICALLY INDUCED; KNEE REPLACEMENT; MIDDLE AGED; OSTEOARTHRITIS, KNEE; RISK ASSESSMENT; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; AGED; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; POSTOPERATIVE HEMORRHAGE; RISK ASSESSMENT; RISK FACTORS; TRANEXAMIC ACID; VENOUS THROMBOEMBOLISM;

EID: 85021288497     PISSN: 15388506     EISSN: 19382480     Source Type: Journal    
DOI: 10.1055/s-0036-1593371     Document Type: Article

References (42)

1. Cram P. Lu X. Kates S. L. Singh J. A. Li Y. Wolf B. R. Total knee arthroplasty volume, utilization, and outcomes among Medicare beneficiaries, 1991-2010. JAMA: 2012; 308 12 1227 1236
2. Kurtz S. Ong K. Lau E. Mowat F. Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am: 2007; 89 04 780 785
3. Mahomed N. N. Barrett J. Katz J. N. Baron J. A. Wright J. Losina E. Epidemiology of total knee replacement in the United States Medicare population. J Bone Joint Surg Am: 2005; 87 06 1222 1228
4. Bierbaum B. E. Callaghan J. J. Galante J. O. Rubash H. E. Tooms R. E. Welch R. B. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am: 1999; 81 01 2 10
5. Noticewala M. S. Nyce J. D. Wang W. Geller J. A. Macaulay W. Predicting need for allogeneic transfusion after total knee arthroplasty. J Arthroplasty: 2012; 27 06 961 967
6. Stokes M. E. Ye X. Shah M., et al. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res: 2011; 11 135
7. Yang Z. G. Chen W. P. Wu L. D. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am: 2012; 94 13 1153 1159
8. Zhang H. Chen J. Chen F. Que W. The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc: 2012; 20 09 1742 1752
9. Dahuja A. Dahuja G. Jaswal V. Sandhu K. A prospective study on role of tranexamic acid in reducing postoperative blood loss in total knee arthroplasty and its effect on coagulation profile. J Arthroplasty: 2014; 29 04 733 735
10. Karam J. A. Bloomfield M. R. DiIorio T. M. Irizarry A. M. Sharkey P. F. Evaluation of the efficacy and safety of tranexamic acid for reducing blood loss in bilateral total knee arthroplasty. J Arthroplasty: 2014; 29 03 501 503
11. Tan J. Chen H. Liu Q. Chen C. Huang W. A meta-analysis of the effectiveness and safety of using tranexamic acid in primary unilateral total knee arthroplasty. J Surg Res: 2013; 184 02 880 887
12. Hunt B. J. The current place of tranexamic acid in the management of bleeding. Anaesthesia: 2015; 70 01 50 53, e18
13. Gomez-Barrena E. Ortega-Andreu M. Padilla-Eguiluz N. G. Pérez-Chrzanowska H. Figueredo-Zalve R. Topical intra-articular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement: a double-blind, randomized, controlled, noninferiority clinical trial. J Bone Joint Surg Am: 2014; 96 23 1937 1944
14. Hiippala S. T. Strid L. J. Wennerstrand M. I., et al. Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg: 1997; 84 04 839 844
15. Kelley T. C. Tucker K. K. Adams M. J. Dalury D. F. Use of tranexamic acid results in decreased blood loss and decreased transfusions in patients undergoing staged bilateral total knee arthroplasty. Transfusion: 2014; 54 01 26 30
16. Atik O. S. Does tranexamic acid reduce blood loss and blood transfusion requirement in knee arthroplasty? Eklem Hastalik Cerrahisi: 2012; 23 03 166 167
17. Krohn C. D. Sorensen R. Lange J. E. Riise R. Bjornsen S. Brosstad F. Tranexamic acid given into the wound reduces postoperative blood loss by half in major orthopaedic surgery. Eur J Surg Suppl: 2003; 588 57 61
18. Alshryda S. Sarda P. Sukeik M. Nargol A. Blenkinsopp J. Mason J. M. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br: 2011; 93 12 1577 1585
19. Patel J. N. Spanyer J. M. Smith L. S. Huang J. Yakkanti M. R. Malkani A. L. Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study. J Arthroplasty: 2014; 29 08 1528 1531
20. Chimento G. F. Huff T. Ochsner J. L. Jr. Meyer M. Brandner L. Babin S. An evaluation of the use of topical tranexamic acid in total knee arthroplasty. J Arthroplasty: 2013; 28 (8, Suppl): 74 77
21. Georgiadis A. G. Muh S. J. Silverton C. D. Weir R. M. Laker M. W. A prospective double-blind placebo controlled trial of topical tranexamic acid in total knee arthroplasty. J Arthroplasty: 2013; 28 (8, Suppl): 78 82
22. Konig G. Hamlin B. R. Waters J. H. Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty. J Arthroplasty: 2013; 28 09 1473 1476
23. Kagoma Y. K. Crowther M. A. Douketis J. Bhandari M. Eikelboom J. Lim W. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res: 2009; 123 05 687 696
24. Wong J. Abrishami A. El Beheiry H., et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am: 2010; 92 15 2503 2513
25. Maniar R. N. Kumar G. Singhi T. Nayak R. M. Maniar P. R. Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin Orthop Relat Res: 2012; 470 09 2605 2612
26. Alvarez J. C. Santiveri F. X. Ramos I. Vela E. Puig L. Escolano F. Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied. Transfusion: 2008; 48 03 519 525
27. Endo Y. Nishimura S. Miura A. Deep-vein thrombosis induced by tranexamic acid in idiopathic thrombocytopenic purpura. JAMA: 1988; 259 24 3561 3562
28. Bruce-Brand R. Dragomir R. Baker J. Harty J. Cerebrovascular infarction following bilateral total knee arthroplasty and tranexamic acid administration. Acta Orthop Belg: 2013; 79 03 351 354
29. Sundström A. Seaman H. Kieler H. Alfredsson L. The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research Database. BJOG: 2009; 116 01 91 97
30. Salam A. King C. Orhan O. Mak V. The great deception: tranexamic acid and extensive pulmonary emboli. BMJ Case Rep 2013; 2013: pii: bcr2012007808
31. Fodstad H. Liliequist B. Spontaneous thrombosis of ruptured intracranial aneurysms during treatment with tranexamic acid (AMCA). Report of three cases. Acta Neurochir (Wien): 1979; 49 (3-4): 129 144
32. Lindoff C. Rybo G. Astedt B. Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications. Thromb Haemost: 1993; 70 02 238 240
33. Gupta P. N. Mullamalla U. R. Sabin P. Vellappan P. Acute MI in a young hypertensive woman: could it be due to tranexamic acid? BMJ Case Rep 2013; 2013: pii: bcr2013009979
34. Duncan C. M. Gillette B. P. Jacob A. K. Sierra R. J. Sanchez-Sotelo J. Smith H. M. Venous thromboembolism and mortality associated with tranexamic acid use during total hip and knee arthroplasty. J Arthroplasty: 2015; 30 02 272 276
35. Whiting D. R. Gillette B. P. Duncan C. Smith H. Pagnano M. W. Sierra R. J. Preliminary results suggest tranexamic acid is safe and effective in arthroplasty patients with severe comorbidities. Clin Orthop Relat Res: 2014; 472 01 66 72
36. Bhat A. Bhowmik D. M. Vibha D. Dogra M. Agarwal S. K. Tranexamic acid overdosage-induced generalized seizure in renal failure. Saudi J Kidney Dis Transpl: 2014; 25 01 130 132
37. Damji K. F. Noël L. P. Peterson R. G., et al. Topical versus intravenous administration of tranexamic acid: a comparison of intraocular and serum concentrations in the rabbit. Can J Ophthalmol: 1998; 33 06 308 313
38. Pilbrant A. Schannong M. Vessman J. Pharmacokinetics and bioavailability of tranexamic acid. Eur J Clin Pharmacol: 1981; 20 01 65 72
39. Seo J. G. Moon Y. W. Park S. H. Kim S. M. Ko K. R. The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc: 2013; 21 08 1869 1874
40. Wind T. C. Barfield W. R. Moskal J. T. The effect of tranexamic acid on blood loss and transfusion rate in primary total knee arthroplasty. J Arthroplasty: 2013; 28 07 1080 1083
41. Ishida K. Tsumura N. Kitagawa A., et al. Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Int Orthop: 2011; 35 11 1639 1645
42. Mantilla C. B. Horlocker T. T. Schroeder D. R. Berry D. J. Brown D. L. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology: 2002; 96 05 1140 1146